![Sandy Mahatme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandy Mahatme
Financieel Directeur/CFO bij
VOR BIOPHARMA INC.
Vermogen: 369 592 $ op 31-05-2026
Profiel
Sandesh Mahatme is currently Director at Epirium Bio, Inc. since 2020, Non-Executive Director at Idorsia Ltd. since 2020, Director at Idorsia Pharmaceuticals Ltd. since 2020, Independent Director at CRISPR Therapeutics AG since 2024, Member of the New York State Bar Association, and will be Chief Financial & Business Officer at Vor Biopharma, Inc. starting in 2025.
Former roles include Independent Director at Elcelyx Therapeutics, Inc., Independent Director at Spyre Therapeutics, Inc. from 2015 to 2022, Independent Director at Flexion Therapeutics, Inc. from 2014 to 2021, Senior VP-Finance & Corporate Development at Celgene Corp.
from 2006 to 2012, Chief Financial & Business Officer, Executive VP at Sarepta Therapeutics, Inc. from 2017 to 2020, Senior Vice President at Celgene Switzerland SARL, and President, Chief Financial & Operating Officer at National Resilience, Inc. from 2020 to 2024.
Education includes graduate degrees from Cornell Law School and New York University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IDORSIA LTD. 0,03% | 31-12-2024 | 64.662 ( 0,03% ) | 369 592 $ | 31-05-2026 |
| 05-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Sandy Mahatme
| Bedrijven | Functie | Begin |
|---|---|---|
| IDORSIA LTD | Directeur/Bestuurslid | 13-05-2020 |
| CRISPR THERAPEUTICS AG | Directeur/Bestuurslid | 30-05-2024 |
| VOR BIOPHARMA INC. | Financieel Directeur/CFO | 09-07-2025 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Directeur/Bestuurslid | 13-10-2020 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Directeur/Bestuurslid | 13-05-2020 |
Eerdere bekende functies van Sandy Mahatme
| Bedrijven | Functie | Einde |
|---|---|---|
National Resilience, Inc.
 National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | President | 01-06-2024 |
| SPYRE THERAPEUTICS, INC. | Directeur/Bestuurslid | 08-07-2022 |
| FLEXION THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-06-2021 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Sandy Mahatme
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
Cornell Law School
 Cornell Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Celgene Switzerland SARL
 Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Operates as a global biopharmaceutical company | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
National Resilience, Inc.
National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Health Technology |
